MENU

Fox Chase Researcher Edna Cukierman Appointed Senior Editor on New Journal

October 19, 2021

Dr. Edna “Eti” Cukierman, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer InstituteDr. Edna “Eti” Cukierman, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute

PHILADELPHIA (October 19, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal.  

Cancer Research Communications, which is being launched by the American Association for Cancer Research (AACR), will be an open-access, peer-reviewed journal that will cover all aspects of cancer research. Cukierman will work on the Tumor Biology section of the journal with a group of associate editors to review and select articles for publication.

“I am thrilled at the opportunity to be included in the emergence of this new open-access journal from the AACR. Being included in an endeavor of this caliber is a new challenge that I am eager to accept,” said Cukierman, who is also co-director of the Immune Monitoring Facility and co-leader of the Cancer Signaling and Epigenetics Program at Fox Chase. “I am very excited to be involved in an AACR project such as this from the ground up.”

Cukierman’s research focuses on pancreatic cancer, specifically the fibrous scar-like tissue cells that make up most of the tumor microenvironment of the pancreas and influence how tumors are established and progress. The tumor microenvironment comprises normal (noncancerous) cells, a plethora of secreted molecules, blood vessels, and other components that surround tumor cells.

Cukierman’s research has been published in a number of prestigious publications, including Cancer Discovery and Cancer Cell. She has also received a number of accolades over the course of her career, including the AACR Career Development Award.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase